Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.
Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...
The researchers demonstrated PAGER's versatility by successfully controlling neuronal activity, triggering immune responses, ...
Immune dysfunction is a condition in which the immune system doesn't work as it should. It can be underactive, which means ...
Macrophages, immune cells typically known for fighting infections, have been discovered to play a vital role in controlling movement and linking neural activity with metabolic demands.
The researchers demonstrated PAGER’s versatility by successfully controlling neuronal activity, triggering immune responses, and delivering therapeutic treatments in lab experiments. While G-protein ...
Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no ...
Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune system recognize ...
Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...